Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.
Biofrontera has raised $8.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in June 2025.
Biofrontera's investors include Rosalind Capital Partners, AIGH Capital Management.
Biofrontera is headquartered in Woburn, United States.
Biofrontera is a biopharmaceutical company specializing in photodynamic therapy and topical antibiotics.
Biofrontera is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Biofrontera — Funding & Investors." VCBacked, June 30, 2025, https://www.vcbacked.co/company/biofrontera. Accessed August 14, 2026.
VCBacked. (2025). Biofrontera — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/biofrontera
{{cite web |title=Biofrontera — Funding & Investors |url=https://www.vcbacked.co/company/biofrontera |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated